Skip to main content
High RiskFDAfda-F-0086-2022UNDECLARED ALLERGEN

Lake Wolf Creamery Queso Oaxaca, ribbon cheese, refrigerated, vacuum packaged in flexible plastic packages, net wt. 3 lbs., 2 lbs., 1.5 l...

Category
Units Affected
40
Recall Date
September 30, 2021
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0086-2022.

The milk pasteurization temperature was not recorded and/or the air space temperature was not at 150F or above as required.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0086-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Lake Wolf Creamery or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0086-2022.

Lake Wolf Creamery

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Lake Wolf Creamery Recall FAQ

Lake Wolf Creamery is the subject of a dairy safety report: Lake Wolf Creamery Queso Oaxaca, ribbon cheese, refrigerated, vacuum packaged in flexible plastic packages, net wt. 3 lbs., 2 lbs., 1.5 l.... The notice was published on September 30, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 40 units are potentially affected.